Annual Meeting Program Committee

 
The Annual Meeting Scientific Program Committee shall consist of three components:
 
  1. Executive Program Committee (Exec PC)
  2. Program Planning Committee
  3. Abstract Reviewers
 
Composition
The Exec PC shall be chaired by the Scientific Program Chair, and shall also include the current President, the Immediate Past Program Chair, the Incoming Scientific Program Chair and the staff member in charge of Scientific Program Planning. The Scientific Program Chair for a given year’s Annual Meeting shall be nominated by the incoming President-Elect, subject to input from the Education Oversight Committee, be approved by the Board, and shall serve as Scientific Program Chair during the nominating President’s term of office.

Responsibilities
  • Serve as advisors to the Scientific Program Chair and provide guidance regarding executive decision-making between meetings of the Program Committee
  • Assist in evaluating and resolving issues that arise that cannot be resolved by staff
  • Solicit and review published, expert, and learner feedback regarding educational needs and identify practice gaps and educational needs to be addressed
  • Develop learning objectives for the Annual Meeting that are tied to the identified practice gaps and educational needs
  • Make every effort to include both new and experienced members on the PPC and among the abstract reviewers, and to ensure specialty, gender, geographic, and generational diversity among each group.
  • Evaluate and prioritize applications for joint symposia with other organizations at the ISHLT Annual Meeting and make recommendations for such to the Board
  • Assist staff in evaluating the effectiveness of the format, structure, and content development process of the Annual Meeting Scientific Program
  • Liaise with and be responsive to the Chair of the Education Oversight Committee with respect to the Board’s strategic objectives, harmonization with other ISHLT educational activities and input from and participation by the Society’s various stakeholders.
 
Composition
  • The Program Planning Committee (PPC) shall consist of the Exec PC members and sufficient additional members necessary to ensure that every eligible Interdisciplinary Network and Professional Community has adequate representation on the PPC.
  • The PPC members shall be appointed by the Scientific Program Chair, in consultation with the Exec PC and in accordance with the below process.
  • The final committee composition is subject to the approval of the Education Oversight Committee.
  • The Chair of the Education Oversight Committee shall serve in an advisory role to the Executive Program Committee. He/she will attend the symposium planning meeting in person, attend the abstract planning meeting via conference call, attend Exec PC conference calls as requested, and be copied on all Exec PC and PPC communications.
  • All Committee terms are for one year.
     
Responsibilities
  • Understand and comply with all conflict of interest (COI) processes and policies and adhere to all COI resolution requirements
  • Understand all ISHLT policies and procedures relevant to the development of the annual meeting scientific program
  • Come prepared and participate actively in all conference calls and meetings
  • Provide content expertise, but seek to create the best overall program rather than advocating for specific content area
  • Ensure that the Annual Meeting Symposia and other invited content address the identified practice gaps and educational needs of the members and the established learning objectives
  • Review and evaluate symposium proposals
  • Select, refine, develop as needed, and schedule the final symposia and other invited content for the Annual Meeting
  • Review submitted abstracts and select those which describe the optimal scientific content for presentation at Annual Meeting
  • Ensure that the presentations to be developed from the chosen abstracts will address the identified practice gaps and educational needs of the members and the established learning objectives
  • Develop and schedule scientific session content based on the selected abstracts
  • Select finalists and/or recipients for the various ISHLT abstract awards
  • PPC Team Leaders:
    • Lead assigned interdisciplinary team’s efforts to assemble symposium content and speakers for presentation to the PPC
    • Communicate effectively with the Exec PC, staff, committee members, and other Team Leaders
    • Ensure that all deadlines are met and that all required information is provided to the Program Chair and staff
  • Professional Community Representatives:
    • The members of the PPC from each Professional Community shall meet once via conference call prior to the Symposium Planning Committee meeting and once via conference call prior to the Abstract Selection Committee meeting to review and assess the scientific content relevant to the interests of their Professional Community and provide feedback to the Exec PC regarding any concerns.
 
Responsibilities
  • Understand and comply with all conflict of interest (COI) processes and policies and adhere to all COI resolution requirements
  • Understand and comply with all ISHLT policies, procedures, and applications relevant to the development of the annual meeting scientific program
  • Review and score all assigned abstracts by the stated deadline
     
Eligibility Criteria / Qualifications / Skill Set
  • Abstract reviewers must be members of ISHLT at the time of appointment and through the date of the meeting
  • Secure and uninterrupted email and internet access with response times not exceeding 48 hours, particularly during the grading period
  • The ability and willingness to block sufficient time during October/November to review and score abstracts via ISHLT’s online scoring system

See Also: Education Oversight Committee

Click on any card below to enlarge for more information. Only ISHLT Members who are logged in can view contact information on the enlarged card.
 
True

Related Items

Peter Hopkins FRACP (ALL)

2021 Program Chair

The Prince Charles Hospital
Brisbane, Australia
Joseph Rogers MD (HEART)

ISHLT President / Cardiology Representative

Duke University
Durham, North Carolina, USA
Laurie Snyder MD (LUNG)

2022 Program Chair / Pulmonology Representative

Duke University
Durham, North Carolina, USA
Stephan Ensminger MD, DPhil (MCS)

2020 Program Chair / Research & Immunology Representative

University of Lubeck
Lubeck, Germany
Howard Eisen MD (HEART)

HEART Team Leader / Cardiology Representative

Penn State Heart and Vascular
Hershey, Pennsylvania, USA
Sandeep Attawar MD (HEART)

Cardiothoracic Surgery Representative

Gleneagles Global Health
Chennai, India
Alejandro Bertolotti MD (HEART)

Cardiothoracic Surgery Representative

Favaloro Foundation University
Buenos Aires, Argentina
Edith Boyes MSN, FNP-BC, CHFN (HEART)

Nursing & Allied Health Representative

AMITA Health
Chicago, Illinois, USA
Javier Carbone MD, PhD (HEART)

Research & Immunology Representative

Hospital General Universitario
Madrid, Spain
Jennifer Conway MD (HEART)

Pediatrics Representative

Stollery Children's Hospital
Edmonton, Alberta, Canada
Jonathan Hand MD (HEART)

Infectious Diseases Representative

Oschner Medical Centre
New Orleans, Louisiana, USA
Daniel Kim MD (HEART)

Cardiology Representative

University of Alberta
Edmonton, Alberta, Canada
Kyung-Hee Kim MD (HEART)

Cardiology Representative

Mediplex Sejong Hospital
Incheon, South Korea
Lynn Punnoose MD (HEART)

Cardiology Representative

Vanderbilt University
Nashville, Tennessee, USA
Maria-Nieves Sanz PhD (HEART)

Research & Immunology Representative

Bern University Hospital
Bern, Switzerland
Carmela Tan MD (HEART)

Pathology Representative

Cleveland Clinic
Cleveland, Ohio, USA
Georgina Waldman PharmD (HEART)

Pharmacy Representative

Massachusetts General Hospital
Boston, Massachusetts, USA
Erika D Lease MD (LUNG)

LUNG Team Leader / Pulmonology Representative

University of Washington
Seattle, Washington, USA
Carl Atkinson PhD (LUNG)

Research & Immunology Representative

Medical University of South Carolina
Charleston, South Carolina, USA
Fay Burrows BPharm (LUNG)

Pharmacy Representative

St. Vincent's Hospital
Sydney, Australia
Hiroshi Date MD (LUNG)

Cardiothoracic Surgery Representative

Kyoto University
Kyoto, Japan
Angela Koutsokera MD, PhD (LUNG)

Pulmonology Representative

Lausanne University Hospital
Lausanne, Switzerland
Brandon Larsen MD (LUNG)

Pathology Representative

Mayo Clinic
Rochester, Minnesota, USA
Bronwyn Levvey RN, Grad Dip Clin Eip (LUNG)

Nursing & Allied Health Representative

Alfred Hospital
Melbourne, Australia
Tereza Martinu MD (LUNG)

Research & Immunology Representative

Toronto General Hospital
Toronto, Ontario, Canada
Tanya McWilliams MD, PhD (LUNG)

Pulmonology Representative

Auckland City Hospital
Auckland, New Zealand
Tina Melicoff MD (LUNG)

Pediatrics Representative

Texas Children's Hospital
Houston, Texas, USA
Caroline Patterson BMBS, MD (LUNG)

Pulmonology Representative

Royal Papworth Hospital
Cambridge, UK
Erik Verschuuren MD, PhD (LUNG)

Infectious Diseases Representative

UMC Groningen Transplant Centre
Groningen, Netherlands
Christopher Wigfield MD, FRCS (LUNG)

Cardiothoracic Surgery Representative

University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, USA
Emma Birks MD, PhD (MCS)

MCS Team Leader / Cardiology Representative

University of Kentucky
Lexington, Kentucky, USA
Yaron D Barac MD, PhD (MCS)

Cardiothoracic Surgery Representative

Rabin Medical Center
Petah Tiqva, Israel
Jesus Casida PhD (MCS)

Nursing & Allied Health Representative

Johns Hopkins University
Baltimore, Maryland, USA
Jerry Estep MD (MCS)

Cardiology Representative

Cleveland Clinic
Cleveland, Ohio, USA
Finn Gustafsson MD, PhD (MCS)

Cardiology Representative

Rigshospitalet
Copenhagen, Denmark
Tomoko Kato MD (MCS)

Cardiology Representative

International University of Health and Welfare
Chiba, Japan
Kewal Krishan MD (MCS)

Cardiothoracic Surgery Representative

Max Super Specialty Hospital Saket
New Delhi, India
Jodie Lantz CNS (MCS)

Pediatrics Representative

Children's Health
Dallas, Texas, USA
Alina Nicoara MD (MCS)

Anesthesiology & Critical Care Representative

Duke University
Durham, North Carolina, USA
Stephanie Pouch MD, MS (MCS)

Infectious Diseases Representative

Emory University
Atlanta, Georgia, USA
Thomas Schloeglhofer MSc (MCS)

Nursing & Allied Health Representative

Medical University of Vienna
Vienna, Austria
Scott Silvestry MD (MCS)

Cardiothoracic Surgery Representative

Advent Health Transplant Institute
Orlando, Florida, USA
Tara Veasey PharmD (MCS)

Pharmacy Representative

Allegheny General Hospital
Pittsburgh, Pennsylvania, USA
John Granton MD (PVD)

PVD Team Leader / Pulmonology Representative

Toronto General Hospital
Toronto, Ontario, Canada
Celine Dewachter MD, PhD (PVD)

Research & Immunology Representative

Erasme Hospital
Brussels, Belgium
Mardi Gomberg-Maitland MD, MSc (PVD)

Cardiology Representative

George Washington University
Washington, DC, USA
David Jenkins MB BS, FRCS (CTh), MS (Lond) (PVD)

Cardiothoracic Surgery Representative

Royal Papworth Hospital
Cambridge, UK
Amy Kiskaddon PharmD (PVD)

Pharmacy Representative

Johns Hopkins All Children's Hospital
St. Petersburg, Florida, USA
Olaf Mercier MD, PhD (PVD)

Cardiothoracic Surgery Representative

Université Paris-Saclay / Marie Lannelongue Hospital - GH Paris Saint Joseph
Paris, France
Desley Neil FRCPath (PVD)

Pathology Representative

Queen Elizabeth Hospital
Birmingham, UK
Erika B Rosenzweig MD (PVD)

Pediatrics Representative

Columbia University Medical Center
New York, New York, USA
Helen Whitford MBBS, FRACP (PVD)

Pulmonology Representative

The Alfred Hospital
Melbourne, Australia